Specially designed visual aids and written materials-intended to help surgeons present treatment options to women newly diagnosed with early-stage breast cancer and to help them participate in the treatment decision process-left women better educated about their disease and treatment options.
Specially designed visual aids and written materials-intended to help surgeons present treatment options to women newly diagnosed with early-stage breast cancer and to help them participate in the treatment decision process-left women better educated about their disease and treatment options. It also left women feeling less conflicted about and more satisfied with their treatment decision, according to this randomized Canadian trial.
The investigation, involving 201 women, used a "decision board" that consisted of a 26 x 20-inch foam board containing details on four areas: treatment choices, side effects, the results of the treatment choice on the breast, and the results of the treatment on survival. Each of these four subtopics were covered for both lumpectomy and radiation and for mastectomy. The teaching tool took about 20 minutes to present and didn't increase the length of the medical consult.
In addition to being more educated about their condition and treatment options, women who used the decision board were more likely to choose breast-conserving therapy over mastectomy and to more strongly prefer their treatment choice.
Multicomponent intervention boosts quality of life in overactive bladder patients
March 15th 2024A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.
Read More
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Read More
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Read More
Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
February 15th 2024A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Read More